The group of DiaCon has launched the production of reagents and spending materials for lifotronic H8 and H9 rolled hemoglobin. All products are fully compatible with these devices, which are widely used in Russian laboratories. The press service of the group of companies informed Gazeta.ru about this.
"Until recently, patients with diabetes depended on the supply of exceptionally imported reagents. Now the necessary materials are manufactured in Russia, which increases the availability of diagnosis and reduces the costs of Diacon, Co-Chair of the Innovation Committee of the Laboratory Medical Federation.
According to experts, there are about six million diabetes in Russia. Timely analyzing of the level of rolled hemoglobin helps to identify the disease complications and choose effective therapy.
"Our own production starts not only in the implementation of the Federal Diabetes Federal Project, but also an important step towards replacing imports in the medical industry. This is directly related to the availability of medical services and security for the population, "Varivoda added.
Translation of: Euromedia24.com
